These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26885596)

  • 1. Use of botulinum toxin type A for the treatment of radiation therapy-induced myokymia and neuromyotonia in a dog.
    Rogatko CP; Glass EN; Kent M; Hammond JJ; de Lahunta A
    J Am Vet Med Assoc; 2016 Mar; 248(5):532-7. PubMed ID: 26885596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myokymia and neuromyotonia in 37 Jack Russell terriers.
    Bhatti SF; Vanhaesebrouck AE; Van Soens I; Martlé VA; Polis IE; Rusbridge C; Van Ham LM
    Vet J; 2011 Sep; 189(3):284-8. PubMed ID: 20724183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myokymia and neuromyotonia in a cat.
    Galano HR; Olby NJ; Howard JF; Shelton GD
    J Am Vet Med Assoc; 2005 Nov; 227(10):1608-12, 1591. PubMed ID: 16313038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inspiratory stridor secondary to palatolingual myokymia in a Maltese dog.
    Vanhaesebrouck AE; Bhatti SF; Bavegems V; Gielen IM; Van Soens I; Vercauteren G; Polis I; Van Ham LM
    J Small Anim Pract; 2010 Mar; 51(3):173-5. PubMed ID: 20070491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-irradiation myokymia and neuromyotonia in unilateral tongue and mentalis muscles: report of a case.
    Liu LH; Chen CW; Chang MH
    Acta Neurol Taiwan; 2007 Mar; 16(1):33-6. PubMed ID: 17486731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Continuous muscle fibre activity' in six dogs with episodic myokymia, stiffness and collapse.
    Van Ham L; Bhatti S; Polis I; Fatzer R; Braund K; Thoonen H
    Vet Rec; 2004 Dec; 155(24):769-74. PubMed ID: 15638001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A for the treatment of postamputation residual limb myokymia: a case report.
    Dave SJ; Salyer J; Desai KA
    PM R; 2010 Aug; 2(8):777-9. PubMed ID: 20709306
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and electrophysiological characterization of myokymia and neuromyotonia in Jack Russell Terriers.
    Vanhaesebrouck AE; Van Soens I; Poncelet L; Duchateau L; Bhatti S; Polis I; Diels S; Van Ham L
    J Vet Intern Med; 2010; 24(4):882-9. PubMed ID: 20492485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyotonia in a dachshund with clinical and electrophysiological signs of spinocerebellar ataxia.
    Vanhaesebrouck AE; Bhatti SF; Polis IE; Plessas IN; Van Ham LM
    J Small Anim Pract; 2011 Oct; 52(10):547-50. PubMed ID: 21967102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized myokymia, or neuromyotonia, or both in dogs with or without spinocerebellar ataxia.
    Vanhaesebrouck A; Van Poucke M; Stee K; Granger N; Ives E; Van Soens I; Cornelis I; Bossens K; Peelman L; Van Ham L; Bhatti SFM
    J Vet Intern Med; 2023; 37(6):2310-2314. PubMed ID: 37905444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-articular botulinum toxin A (BoNT/A) for pain management in dogs with osteoarthritis secondary to hip dysplasia: A randomized controlled clinical trial.
    Nicácio GM; Luna SPL; Cavaleti P; Cassu RN
    J Vet Med Sci; 2019 Mar; 81(3):411-417. PubMed ID: 30643103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
    Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
    Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous facial myokymia in multiple sclerosis: treatment with botulinum toxin.
    Sedano MJ; Trejo JM; Macarrón JL; Polo JM; Berciano J; Calleja J
    Eur Neurol; 2000; 43(3):137-40. PubMed ID: 10765052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of botulinum toxin type A in the management of neonatal brachial plexus palsy.
    Michaud LJ; Louden EJ; Lippert WC; Allgier AJ; Foad SL; Mehlman CT
    PM R; 2014 Dec; 6(12):1107-19. PubMed ID: 24798262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myokymia and neuromyotonia in veterinary medicine: a comparison with peripheral nerve hyperexcitability syndrome in humans.
    Vanhaesebrouck AE; Bhatti SF; Franklin RJ; Van Ham L
    Vet J; 2013 Aug; 197(2):153-62. PubMed ID: 23583699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioprotection of tendon repair: adjunctive use of botulinum toxin A in Achilles tendon repair in the rat.
    Ma J; Shen J; Smith BP; Ritting A; Smith TL; Koman LA
    J Bone Joint Surg Am; 2007 Oct; 89(10):2241-9. PubMed ID: 17908902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of botulinum toxin A for treatment of possible essential blepharospasm in a dog.
    Meyer-Lindenberg A; Wohlfarth KM; Switzer EN
    Aust Vet J; 2003 Oct; 81(10):612-4. PubMed ID: 15080472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular pressure before and after botulinum toxin in chronic exertional compartment syndrome of the leg: a preliminary study.
    Isner-Horobeti ME; Dufour SP; Blaes C; Lecocq J
    Am J Sports Med; 2013 Nov; 41(11):2558-66. PubMed ID: 23969633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.